Tango Therapeutics, Inc.TNGXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+11.4%
5Y CAGR+38.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+11.4%/yr
Annual compound
5Y CAGR
+38.2%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$41.51M-5.1%
2024$43.75M+23.2%
2023$35.50M+18.2%
2022$30.02M+70.6%
2021$17.60M+113.5%
2020$8.24M+9.3%
2019$7.54M-